Indobufen
![]() | |
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | B01AC10 (WHO) |
| Identifiers | |
| |
| CAS Number |
63610-08-2 |
| PubChem (CID) | 107641 |
| ChemSpider |
96823 |
| UNII |
6T9949G4LZ |
| KEGG |
D07141 |
| ChEMBL |
CHEMBL1765292 |
| ECHA InfoCard | 100.058.496 |
| Chemical and physical data | |
| Formula | C18H17NO3 |
| Molar mass | 295.333 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Indobufen is a platelet aggregation inhibitor.[1] It acts as a reversible cyclooxygenase inhibitor.[2]
References
- ↑ The Merck Index, 12th Edition. 4991
- ↑ Eligini, Sonia; Violi, F; Banfi, C; Barbieri, SS; Brambilla, M; Saliola, M; Tremoli, E; Colli, S (2005). "Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism". Cardiovascular Research. 69 (1): 218–226. doi:10.1016/j.cardiores.2005.07.013. PMID 16154551.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.

